Annual EBIT:
-$101.86M-$53.69M(-111.45%)Summary
- As of today, DNTH annual earnings before interest & taxes is -$101.86 million, with the most recent change of -$53.69 million (-111.45%) on December 31, 2024.
- During the last 3 years, DNTH annual EBIT has fallen by -$27.17 million (-36.38%).
- DNTH annual EBIT is now -999.09% below its all-time high of -$9.27 million, reached on December 1, 2016.
Performance
DNTH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$40.29M-$5.36M(-15.35%)Summary
- As of today, DNTH quarterly earnings before interest & taxes is -$40.29 million, with the most recent change of -$5.36 million (-15.35%) on September 30, 2025.
- Over the past year, DNTH quarterly EBIT has dropped by -$10.39 million (-34.74%).
- DNTH quarterly EBIT is now -737.41% below its all-time high of -$4.81 million, reached on March 1, 2017.
Performance
DNTH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$140.31M-$10.39M(-8.00%)Summary
- As of today, DNTH TTM earnings before interest & taxes is -$140.31 million, with the most recent change of -$10.39 million (-8.00%) on September 30, 2025.
- Over the past year, DNTH TTM EBIT has dropped by -$57.40 million (-69.24%).
- DNTH TTM EBIT is now -2816.40% below its all-time high of -$4.81 million, reached on March 1, 2017.
Performance
DNTH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DNTH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -111.5% | -34.7% | -69.2% |
| 3Y3 Years | -36.4% | -388.1% | -99.5% |
| 5Y5 Years | -22.8% | -119.2% | -66.5% |
DNTH EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -242.9% | at low | -424.4% | at low | -265.3% | at low |
| 5Y | 5-Year | -242.9% | at low | -424.4% | at low | -265.3% | at low |
| All-Time | All-Time | -999.1% | at low | -737.4% | at low | -2816.4% | at low |
DNTH EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$40.29M(-15.3%) | -$140.31M(-8.0%) |
| Jun 2025 | - | -$34.93M(-5.3%) | -$129.92M(-10.9%) |
| Mar 2025 | - | -$33.18M(-4.0%) | -$117.20M(-15.1%) |
| Dec 2024 | -$101.86M(-111.5%) | -$31.92M(-6.7%) | -$101.86M(-22.9%) |
| Sep 2024 | - | -$29.90M(-34.7%) | -$82.90M(-20.6%) |
| Jun 2024 | - | -$22.20M(-24.4%) | -$68.76M(-17.9%) |
| Mar 2024 | - | -$17.84M(-37.7%) | -$58.34M(-21.1%) |
| Dec 2023 | -$48.17M(-62.2%) | -$12.96M(+17.8%) | -$48.17M(-4.9%) |
| Sep 2023 | - | -$15.76M(-33.8%) | -$45.91M(-19.5%) |
| Jun 2023 | - | -$11.78M(-53.3%) | -$38.41M(+14.1%) |
| Mar 2023 | - | -$7.68M(+28.1%) | -$44.71M(+26.5%) |
| Dec 2022 | -$29.70M(+60.2%) | -$10.69M(-29.5%) | -$60.86M(+13.4%) |
| Sep 2022 | - | -$8.25M(+54.4%) | -$70.31M(+12.4%) |
| Jun 2022 | - | -$18.08M(+24.1%) | -$80.30M(-0.6%) |
| Mar 2022 | - | -$23.83M(-18.3%) | -$79.83M(-6.9%) |
| Dec 2021 | -$74.69M | - | - |
| Dec 2021 | - | -$20.14M(-10.4%) | -$74.69M(-1.5%) |
| Sep 2021 | - | -$18.25M(-3.6%) | -$73.62M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$17.61M(+5.8%) | -$73.75M(+3.2%) |
| Mar 2021 | - | -$18.70M(+1.9%) | -$76.16M(+3.2%) |
| Dec 2020 | -$78.70M(+5.1%) | -$19.07M(-3.7%) | -$78.70M(+6.6%) |
| Sep 2020 | - | -$18.38M(+8.2%) | -$84.27M(+4.8%) |
| Jun 2020 | - | -$20.01M(+5.8%) | -$88.54M(-0.8%) |
| Mar 2020 | - | -$21.24M(+13.8%) | -$87.86M(-5.9%) |
| Dec 2019 | -$82.97M(-38.4%) | -$24.64M(-8.8%) | -$82.97M(-8.8%) |
| Sep 2019 | - | -$22.64M(-17.1%) | -$76.26M(-8.4%) |
| Jun 2019 | - | -$19.34M(-18.3%) | -$70.32M(-8.2%) |
| Mar 2019 | - | -$16.35M(+8.8%) | -$65.01M(-8.4%) |
| Dec 2018 | -$59.96M(-67.8%) | -$17.93M(-7.4%) | -$59.96M(-42.7%) |
| Sep 2018 | - | -$16.70M(-19.1%) | -$42.03M(-29.9%) |
| Jun 2018 | - | -$14.03M(-24.0%) | -$32.35M(+5.0%) |
| Mar 2018 | - | -$11.31M(-61.2%) | -$34.05M(-23.6%) |
| Dec 2017 | -$35.73M(-285.5%) | - | - |
| Sep 2017 | - | -$7.01M(+55.4%) | -$27.56M(-34.1%) |
| Jun 2017 | - | -$15.73M(-227.0%) | -$20.54M(-327.0%) |
| Mar 2017 | - | -$4.81M | -$4.81M |
| Dec 2016 | -$9.27M | - | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual EBIT year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Dianthus Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. TTM EBIT year-on-year change?
What is Dianthus Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of DNTH is -$101.86M
What is the all-time high annual EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$9.27M
What is Dianthus Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, DNTH annual earnings before interest & taxes has changed by -$53.69M (-111.45%)
What is Dianthus Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of DNTH is -$40.29M
What is the all-time high quarterly EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$4.81M
What is Dianthus Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, DNTH quarterly earnings before interest & taxes has changed by -$10.39M (-34.74%)
What is Dianthus Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of DNTH is -$140.31M
What is the all-time high TTM EBIT for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$4.81M
What is Dianthus Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, DNTH TTM earnings before interest & taxes has changed by -$57.40M (-69.24%)